LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 192 filers reported holding LEGEND BIOTECH CORP in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,955,374 | +9.1% | 207,762 | +12.1% | 0.00% | +33.3% |
| Q2 2023 | $12,791,190 | +206.2% | 185,299 | +113.9% | 0.00% | +200.0% |
| Q1 2023 | $4,177,346 | -26.7% | 86,631 | -24.2% | 0.00% | -50.0% |
| Q4 2022 | $5,701,912 | +27.1% | 114,221 | +3.9% | 0.00% | +100.0% |
| Q3 2022 | $4,487,000 | -4.6% | 109,981 | +28.6% | 0.00% | 0.0% |
| Q2 2022 | $4,702,000 | +117.5% | 85,497 | +43.7% | 0.00% | 0.0% |
| Q1 2022 | $2,162,000 | -20.0% | 59,496 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $2,702,000 | +27.0% | 57,949 | +15.9% | 0.00% | 0.0% |
| Q2 2020 | $2,128,000 | – | 50,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |